<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30044058</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>25</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2045-7634</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>7</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer medicine</Title>                <ISOAbbreviation>Cancer Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Radiation-associated sarcoma after breast cancer in a nationwide population: Increasing risk of angiosarcoma.</ArticleTitle>            <Pagination>                <MedlinePgn>4825-4835</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.1698</ELocationID>            <Abstract>                <AbstractText>Radiation-associated sarcoma (RAS) is a rare complication of radiation therapy (RT) to breast cancer (BC). This study explored RAS after RT to BC in a nationwide population-based material. The Finnish Cancer Registry was queried for patients with BC treated during 1953-2014 who were later diagnosed with a secondary sarcoma in 1953-2014. Registry data, patient files, and sarcoma specimens were  analyzed to confirm diagnosis and location of RAS at or close to the RT target volume. A total of 132 512 patients were diagnosed with invasive BC during the study period. A subsequent sarcoma was diagnosed in 355 patients. After exclusion, 96 RAS were identified. Angiosarcoma (AS) was the most prevalent histology in 50 (52%) of 96 patients. However, the first radiation-associated AS was diagnosed in a patient treated for BC with breast-conserving surgery in 1984, and thereafter, the proportion of AS continuously increased. The 5-year sarcoma-specific survival was 75.1% for RAS treated with a curative intent. The distribution of histologic subtypes of RAS has changed during the 60 years of this registry study. The first radiation-associated AS was diagnosed in 1989, and presently, AS is the most common histologic subtype of RAS. It is possible that changes in BC treatment strategies are influencing the characteristics of RAS.</AbstractText>                <CopyrightInformation>© 2018 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Salminen</LastName>                    <ForeName>Samuli H</ForeName>                    <Initials>SH</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Cancer Center, Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sampo</LastName>                    <ForeName>Mika M</ForeName>                    <Initials>MM</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9454-4495</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Helsinki and HUSLAB Helsinki University Hospital, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Böhling</LastName>                    <ForeName>Tom O</ForeName>                    <Initials>TO</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Helsinki and HUSLAB Helsinki University Hospital, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tuomikoski</LastName>                    <ForeName>Laura</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Cancer Center, Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tarkkanen</LastName>                    <ForeName>Maija</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Cancer Center, Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Blomqvist</LastName>                    <ForeName>Carl P</ForeName>                    <Initials>CP</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Cancer Center, Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Örebro University Hospital, Örebro, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>Competitive Research Funding of Helsinki University Hospital</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Finnish Cancer Society</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>25</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cancer Med</MedlineTA>            <NlmUniqueID>101595310</NlmUniqueID>            <ISSNLinking>2045-7634</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2005 Mar;12(3):237-45</RefSource>                <PMID Version="1">15827816</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2010 Oct;19(5):424-7</RefSource>                <PMID Version="1">20542697</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1992;23(5):915-23</RefSource>                <PMID Version="1">1639653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1998 Dec;34(13):2068-75</RefSource>                <PMID Version="1">10070313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2012 Jan 17;106(2):297-306</RefSource>                <PMID Version="1">22173669</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2012 May;105(6):570-6</RefSource>                <PMID Version="1">22012601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2006 Oct;130(10):1448-53</RefSource>                <PMID Version="1">17090186</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1991 Aug 1;68(3):524-31</RefSource>                <PMID Version="1">2065271</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2000 Jul;216(1):197-205</RefSource>                <PMID Version="1">10887248</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1988 Dec 1;62(11):2330-40</RefSource>                <PMID Version="1">3179948</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2005 Feb;89(3):277-88</RefSource>                <PMID Version="1">15754127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1998 Jan 1;82(1):8-34</RefSource>                <PMID Version="1">9428476</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2018 Sep;7(9):4825-4835</RefSource>                <PMID Version="1">30044058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2012 May 15;118(10):2682-92</RefSource>                <PMID Version="1">21989796</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2002 Oct 17;347(16):1233-41</RefSource>                <PMID Version="1">12393820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1948 May;1(1):64-81</RefSource>                <PMID Version="1">18867440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1984 Dec 1;54(11):2319-23</RefSource>                <PMID Version="1">6498728</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 2009 Jun;35(6):654-9</RefSource>                <PMID Version="1">19112005</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1992 Aug 1;70(3):644-7</RefSource>                <PMID Version="1">1320451</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sarcoma. 2008;2008:459386</RefSource>                <PMID Version="1">18497869</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2017 May;77:31-39</RefSource>                <PMID Version="1">28350996</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 1997 Mar 22;314(7084):864-7</RefSource>                <PMID Version="1">9093096</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):361-7</RefSource>                <PMID Version="1">1648044</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2005 Aug 15;104(4):856-63</RefSource>                <PMID Version="1">15981282</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):883-7</RefSource>                <PMID Version="1">20087653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res Treat. 2016 Apr;48(2):650-7</RefSource>                <PMID Version="1">27004955</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1971 Nov;28(5):1087-99</RefSource>                <PMID Version="1">5288429</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 1985 Mar;28(3):168-71</RefSource>                <PMID Version="1">3838353</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Chir Belg. 2008 Sep-Oct;108(5):574-9</RefSource>                <PMID Version="1">19051469</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Apr 20;28(12):2064-9</RefSource>                <PMID Version="1">20308666</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2017 Jul 25;117(3):326-331</RefSource>                <PMID Version="1">28654633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2009 Sep 15;115(18):4055-63</RefSource>                <PMID Version="1">19526590</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Bone Joint Surg Br. 2007 Jun;89(6):808-13</RefSource>                <PMID Version="1">17613509</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Surg. 1986 Apr;73(4):308-9</RefSource>                <PMID Version="1">3697664</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">hemangiosarcoma</Keyword>            <Keyword MajorTopicYN="N">radiotherapy</Keyword>            <Keyword MajorTopicYN="N">registries</Keyword>            <Keyword MajorTopicYN="N">sarcoma</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30044058</ArticleId>            <ArticleId IdType="doi">10.1002/cam4.1698</ArticleId>            <ArticleId IdType="pmc">PMC6143936</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>